Gene · 23600
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and Validation of a Pathological Upgrading Prediction Model for Low-grade Gastric Mucosal Dysplasia. | Altern Ther Health Med | 2024 | 38940773 | PubTator, text mining | PubMed |
| The importance of histomorphological features and ERG expression in the diagnosis of malignancy in cases with atypical small acinar proliferation. | J Pathol Transl Med | 2024 | 38766739 | PubTator, text mining | PubMed |
| Multiplexed Opto-Microfluidic Biosensing: Advanced Platform for Prostate Cancer Detection. | ACS Sens | 2024 | 38683677 | PubTator, text mining | PubMed |
| Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model. | Sci Rep | 2024 | 38632341 | PubTator, text mining | PubMed |
| Alpha-methyl CoA racemase (AMACR) reactivity across the spectrum of clear cell renal cell neoplasms. | Ann Diagn Pathol | 2024 | 38579443 | PubTator, text mining | PubMed |
| Histomorphometric and Immunohistochemical Diagnosis of Renal Cell Carcinoma: Review Article. | Mymensingh Med J | 2024 | 38557550 | PubTator, text mining | PubMed |
| Serum Fusion Transcripts to Assess the Risk of Hepatocellular Carcinoma and the Impact of Cancer Treatment through Machine Learning. | Am J Pathol | 2024 | 38537933 | PubTator, text mining | PubMed |
| Dysregulated proteome and N-glycoproteome in ALG1-deficient fibroblasts. | Proteomics | 2024 | 38470198 | PubTator, text mining | PubMed |
| Invasive micropapillary urothelial carcinoma of the renal pelvis presenting as nonfunctional kidney: A unique presentation and review of the literature. | Indian J Pathol Microbiol | 2024 | 38394422 | PubTator, text mining | PubMed |
| Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas. | Virchows Arch | 2024 | 38388964 | PubTator, text mining | PubMed |
| Spatial characterisation of β-catenin-mutated hepatocellular adenoma subtypes by proteomic profiling of the tumour rim. | JHEP Rep | 2024 | 38304236 | PubTator, text mining | PubMed |
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System. | Int J Mol Sci | 2024 | 38279253 | PubTator, text mining | PubMed |
| Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives. | Mol Cancer | 2024 | 38262996 | PubTator, text mining | PubMed |
| Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research. | Int J Mol Sci | 2024 | 38256166 | PubTator, text mining | PubMed |
| Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases. | Pathol Res Pract | 2024 | 38241777 | PubTator, text mining | PubMed |
| Extraskeletal conventional chondrosarcoma of genitalia in a child- An unusual pathology for a rare tumor. | Int J Surg Case Rep | 2024 | 38237415 | PubTator, text mining | PubMed |
| An unusual uterine papillary serous carcinoma with post therapy disseminating metastasis presenting as primary renal malignancy: a case report. | Ann Med Surg (Lond) | 2024 | 38222732 | PubTator, text mining | PubMed |
| Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer. | Clin Epigenetics | 2024 | 38173042 | PubTator, text mining | PubMed |
| Solitary vertebral metastasis of unknown primary renal cell carcinoma treated with surgical resection plus tyrosine kinase inhibitor: A case report. | Int J Surg Case Rep | 2024 | 38171274 | PubTator, text mining | PubMed |
| Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases. | Neoplasia | 2024 | 38142529 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23600/papers?page=7